insights_auto
Why is BMY down २.९९%?
Dive Deeperchevron_right
BMY:NYSE
Bristol-Myers Squibb Co
US$ ५७.३४
arrow_downward
-२.९९%(-१.७७) 1D
अक्टोबर १२, १२:१८:२३ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMY...
Open
US$ ६०.११
High
US$ ६०.६८
Low
US$ ५६.८०
Mkt. cap
१.१७ खरब
Avg. vol.
१.१४ करोड
Volume
९०.५९ लाख
Dividend
४.३९%
Quarterly dividend
US$ ०.६३
Ex-dividend date
२०२६ अक्टोबर २
P/E ratio
१२.६३
52-wk high
US$ ६८.६४
52-wk low
US$ ४२.५२
EPS
US$ ४.५४
Beta
०.१९
Shares outstanding
२.०४ अरब
No. of employees
३२ हजार
Open
US$ ६०.११
High
US$ ६०.६८
Low
US$ ५६.८०
Mkt. cap
१.१७ खरब
Avg. vol.
१.१४ करोड
Volume
९०.५९ लाख
Dividend
४.३९%
Quarterly dividend
US$ ०.६३
Ex-dividend date
२०२६ अक्टोबर २
P/E ratio
१२.६३
52-wk high
US$ ६८.६४
52-wk low
US$ ४२.५२
EPS
US$ ४.५४
Beta
०.१९
Shares outstanding
२.०४ अरब
No. of employees
३२ हजार
News stories
From web sources and news partners
GuruFocus
·
१५ मिनेट पहिले
Bristol Myers Squibb (BMY) Reports Positive Phase 3 Trial Results for Admilparant in IPF
Yahoo Finance
·
२३ मिनेट पहिले
BMS gains two pivotal trial wins in lung disease and rare cancer
Quiver Quantitative
·
४६ मिनेट पहिले
Why Bristol Myers Squibb (BMY) Stock Is Down Today
Zacks Investment Research
·
१ घण्टा पहिले
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOChris Boerner
Employees३२.५ हजार
Founded१८८७
Headquartersन्यू योर्क शहर, न्यू योर्क, संयुक्त राज्य अमेरिका
Sector-
Websitebms.com